Neil Bhowmick, PhD | Authors

Plasma Glutamine as a Prognostic Biomarker in Localized Prostate Cancer: Comparison of Conventional Variables in Risk Stratification

September 14, 2021

This study investigated the biomarker potential of glutamine among known prognostic variables in localized prostate cancer.

Integrating PARP Inhibitors Into Advanced Prostate Cancer Therapeutics

March 17, 2021

Experts in the field review integration of approved PARP inhibitors into advanced prostate cancer clinical practice.